ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

Rhea-AI Summary

ANI Pharmaceuticals (ANIP) has announced its participation in two major healthcare investor conferences in March 2025. The company's President and CEO, Nikhil Lalwani, along with senior management members, will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on March 4 at 1:40 PM ET and the Leerink Partners Global Healthcare Conference on March 11 at 3:40 PM ET.

Both presentations will be available via live and archived webcasts on ANI's website (www.anipharmaceuticals.com) under the Investors section's Events and Presentations area. The webcast replays will remain accessible for 90 days following the events.

PRINCETON, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and select members of senior management, will present at two upcoming investor conferences as follows:

• Raymond James & Associates’ 46^th Annual Institutional Investors Conference
  Tuesday, March 4, 2025, at 1:40pm ET

• Leerink Partners Global Healthcare Conference
  Tuesday, March 11, 2025, at 3:40pm ET

The live and archived webcasts will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business. For more information, visit www.anipharmaceuticals.com.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When will ANI Pharmaceuticals (ANIP) present at the Raymond James Conference in March 2025?

ANI Pharmaceuticals will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025, at 1:40 PM ET.

What time is ANIP's presentation at the Leerink Partners Conference in March 2025?

ANI Pharmaceuticals will present at the Leerink Partners Global Healthcare Conference on Tuesday, March 11, 2025, at 3:40 PM ET.

How long will ANIP's March 2025 conference webcasts be available for replay?

The webcast replays will be accessible for 90 days on ANI Pharmaceuticals' website under the Investors section.

Where can investors access ANIP's March 2025 conference presentations?

Investors can access the live and archived webcasts through ANI Pharmaceuticals' website (www.anipharmaceuticals.com) under the Investors section's Events and Presentations area.